PTC Therapeutics, Inc. (PTCT) income statement
PTCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 5/3023% above fair value
$56.42−1.91 (-3.27%)
Close on Nov 20, 2026Market cap $4.71BP/E –Yield –
PTC Therapeutics, Inc. financial ratios
See a number that looks wrong?